1 2 3 4 5 6 7 8 9 10

News Archive

Still some places for MS follow up retreat at Gawler Foundation end of May

May 2011
For those who have previously been to a Gawler retreat, an opportunity to refresh and invigorate Read more >
Buffalo study on CCSVI published

Apr 2011
The long awaited results of the Buffalo study examining chronic cerebrospinal venous insufficiency (CCSVI) have now been published on-line ahead of print. Read more >
Medical Journal of Australia calls for routine vitamin D testing in pregnancy

Apr 2011
It has taken some time for mainstream medicine to catch up with the vitamin D deficiency epidemic, but at last this editorial makes a strong case for routine vitamin D testing during pregnancy Read more >
Predictors of which children with demyelination will go on to develop MS

Apr 2011
A large group of researchers from the Toronto Hospital for Sick Children have investigated the predictive factors for which children with an acute demyelinating event will go on to develop MS. The usual culprits turned up: low vitamin D, glandular fever infection, and the known genetic predisposition (one or more HLA-DRB1*15 alleles). Read more >
Positive long term results of stem cell transplantation in MS

Mar 2011
In a study following up patients after stem cell transplantation for a median of 11 years, Greek researchers have found the therapy effective in the long term in reducing disease activity for those with aggressive MS Read more >
Passive smoking increases the risk of MS

Mar 2011
Researchers from the Karolinska Institute in Sweden have confirmed that passive smoking increases the risk of developing multiple sclerosis Read more >
Intestinal parasite administration is anti-inflammatory and reduces disease activity in MS

Mar 2011
There has been conjecture that the administration of intestinal parasites might cause an immune response beneficial to people with MS. This pilot study shows it is likely to be helpful, and paves the way for larger studies. Read more >
The journal Emergency Medicine Australasia stops all drug company advertising

Feb 2011
In an editorial in Emergency Medicine Australasia, Professors Jelinek and Brown, Emeritus Editor and Editor-in-Chief, describe why they have decided to stop all drug company advertising in the journal. Read more >
Double dose Copaxone no better than standard dose

Jan 2011
A large international randomised controlled trial has shown no difference between double dose (40mg) Copaxone and standard dose (20mg) Copaxone. Read more >
Prof Jelinek's research on live-in MS retreats featured on ABC TV

Dec 2010
The ABC has featured Prof Jelinek's newly published research showing the benefit of live-in retreats for people with MS on its current affairs show The 7.30 Report Read more >